LAMP1 and central nervous system cancer: In a representative study that has been repeated at least 3 times, NY-ESO-1 specific CD8+ T cells, gated from the CD3+CD8+ population, exhibited a 7% or a 68% expression of CD107A when co-cultured with control or decitabine-treated T98 glioma cells, respectively (Figure 4B).